Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.

<h4>Background</h4> <p>Biomarkers of intestinal inflammation, faecal calprotectin (FC) and C-reactive protein (CRP), have been recommended to monitor patients with Crohn’s disease (CD), but whether their use in treatment decisions improves outcomes remains unknown. In CALM, we com...

全面介绍

书目详细资料
Main Authors:	Colombel, J, Panaccione, R, Bossuyt, P, Lukas, M, Baert, F, Vanasek, T, Danalioglu, A, Novacek, G, Armuzzi, A, Hébuterne, X, Travis, S, Danese, S, Reinisch, W, Sandborn, W, Rutgeerts, P, Hommes, D, Schreiber, S, Neimark, E, Huang, B, Zhou, Q, Mendez, P, Petersson, J, Wallace, K, Robinson, A, Thakkar, R, D'Haens, G
格式:	Journal article
语言:	English
出版:	Elsevier 2017

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.

相似书籍